Aller au contenu principal
2025 conference-abstract

Abstract 4370739: Integrative analysis of MoTrPAC and LINCS transcriptomes identifies cardiovascular-relevant exercise-mimetic drugs

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Introduction: Exercise is a cornerstone of cardiovascular health, yet not all individuals can engage in sufficient physical activity. Identifying pharmacological agents that mimic exercise-induced molecular adaptations offers a promising strategy for disease prevention. Here, we integrate transcriptomic data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC)—a multi-omics effort characterizing exercise responses—including human skeletal muscle after acute exercise (0-24h), and both acute and endurance training (1-8 weeks) in rat heart and skeletal muscle. These are combined with the Library of Integrated Network-Based Cellular Signatures (LINCS), which catalogs drug-induced transcriptional responses in 292 human cell lines exposed to 20,272 compounds. Through this integrative approach, we aim to identify compounds that replicate transcriptional effects of endurance exercise. Methods: To address transcriptomic differences between tissues and cell lines, we developed a pipeline combining functional and regulatory analyses. We assessed pathway enrichment via FGSEA and inferred transcription factor (TF) activity using VIPER and DoRothEA (Figure 1A). Shared pathways and upstream regulators were integrated into a mimetic score ranking candidate drugs by their functional and regulatory similarity to exercise. Results: We identified between 600–800 candidate mimetics for skeletal muscle in acute human and rat responses, as well as during endurance training. Notably, predicted mimetics aligned well between species (Figure 1B). Among top hits, midodrine, an α1-adrenergic agonist investigating for its cardioprotective properties, matched 24h post-exercise signatures in both species and activated TFs linked to mitochondrial function, vascular remodeling, and metabolism (FOXP1, CREB1). PD-0325901, a MEK inhibitor, showed strong similarity to early phases (15–45 min), inducing early-response TFs (FOS, HIF1A, RELA), and reflected endurance training upregulation of oxidative phosphorylation. Mimetic profiles from rat heart clustered with muscle at matched timepoints, highlighting the potential to extend heart-based predictions to humans via conserved signatures (Figure 1C). Conclusion: This integrative analysis identifies candidate compounds that mimic distinct phases of exercise-induced molecular remodeling. Ongoing validation in cardiac models aims to translate these findings into cardiovascular contexts.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Abstract 4370739: Integrative analysis of MoTrPAC and LINCS transcriptomes identifies cardiovascular-relevant exercise-mimetic drugs
Date Crossref
04/11/2025
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Adipose Tissue and MetabolismSingle-cell and spatial transcriptomicsGDF15 and Related Biomarkers

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.